Document Detail

Pharmacologic control of heart rate in atrial fibrillation.
MedLine Citation:
PMID:  8950054     Owner:  NLM     Status:  MEDLINE    
Atrial fibrillation is associated with a resting heart rate in excess of age-matched subjects in sinus rhythm, and there is an additional steep rise in rate during exertion. This article reviews the factors responsible for this tachycardia, the pharmacologic agents commonly used for heart rate control, and the effects of atrial antiarrhythmic agents on the heart rate during paroxysmal atrial fibrillation.
R H Falk
Related Documents :
970334 - Quinidine-induced ventricular flutter and fibrillation without digitalis therapy.
17543664 - Atrial fibrillation in the wolff-parkinson-white syndrome: ecg recognition and treatmen...
8149754 - Recent atrial fibrillation in acute myocardial infarction: a sign of pericarditis.
2769174 - Primary ventricular fibrillation in acute myocardial infarction.
15030274 - Intracoronary pressure and flow velocity for hemodynamic evaluation of coronary stenoses.
11576364 - Severity of renal vascular disease predicts mortality in patients undergoing coronary a...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Cardiology clinics     Volume:  14     ISSN:  0733-8651     ISO Abbreviation:  Cardiol Clin     Publication Date:  1996 Nov 
Date Detail:
Created Date:  1997-03-14     Completed Date:  1997-03-14     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  8300331     Medline TA:  Cardiol Clin     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  521-36     Citation Subset:  IM    
Boston University School of Medicine, Massachusetts, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adrenergic beta-Antagonists / pharmacology,  therapeutic use*
Anti-Arrhythmia Agents / pharmacology,  therapeutic use*
Atrial Fibrillation / drug therapy*,  physiopathology*
Calcium Channel Blockers / pharmacology,  therapeutic use*
Digoxin / pharmacology,  therapeutic use*
Heart Rate* / drug effects,  physiology
Heart Ventricles / physiopathology
Magnesium / pharmacology,  therapeutic use*
Physical Exertion / physiology
Rest / physiology
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 0/Anti-Arrhythmia Agents; 0/Calcium Channel Blockers; 20830-75-5/Digoxin; 7439-95-4/Magnesium

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Antiarrhythmic drug therapy in the treatment of atrial fibrillation.
Next Document:  Prevention of thromboembolism in patients with atrial fibrillation.